Tags

Type your tag names separated by a space and hit enter

Bromocriptine in hyperprolactinemic amenorrhea: a possible early effect on ovarian steroidogenesis.
Int J Fertil. 1979; 24(2):145-7.IJ

Abstract

The effect of bromocriptine was studied in a 28-year-old cretin woman who presented with long-term untreated primary hypothyroidism, primary amenorrhea, hyperprolactinemia, and an enlarged pituitary fossa. Bromocriptine therapy lowered the plasma prolactin and caused an early rise in plasma 17 beta-estradiol levels and uterine bleeding, despite the failure of plasma gonadotrophins to respond to luteinizing hormone release hormone (LHRH) administration. Thus, it is suggested that bromocriptine may have an early direct effect on the ovary in hyperprolactinemic amenorrhea.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

40911

Citation

Le Roith, D, et al. "Bromocriptine in Hyperprolactinemic Amenorrhea: a Possible Early Effect On Ovarian Steroidogenesis." International Journal of Fertility, vol. 24, no. 2, 1979, pp. 145-7.
Le Roith D, Potashnik G, Glick SM. Bromocriptine in hyperprolactinemic amenorrhea: a possible early effect on ovarian steroidogenesis. Int J Fertil. 1979;24(2):145-7.
Le Roith, D., Potashnik, G., & Glick, S. M. (1979). Bromocriptine in hyperprolactinemic amenorrhea: a possible early effect on ovarian steroidogenesis. International Journal of Fertility, 24(2), 145-7.
Le Roith D, Potashnik G, Glick SM. Bromocriptine in Hyperprolactinemic Amenorrhea: a Possible Early Effect On Ovarian Steroidogenesis. Int J Fertil. 1979;24(2):145-7. PubMed PMID: 40911.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Bromocriptine in hyperprolactinemic amenorrhea: a possible early effect on ovarian steroidogenesis. AU - Le Roith,D, AU - Potashnik,G, AU - Glick,S M, PY - 1979/1/1/pubmed PY - 1979/1/1/medline PY - 1979/1/1/entrez SP - 145 EP - 7 JF - International journal of fertility JO - Int J Fertil VL - 24 IS - 2 N2 - The effect of bromocriptine was studied in a 28-year-old cretin woman who presented with long-term untreated primary hypothyroidism, primary amenorrhea, hyperprolactinemia, and an enlarged pituitary fossa. Bromocriptine therapy lowered the plasma prolactin and caused an early rise in plasma 17 beta-estradiol levels and uterine bleeding, despite the failure of plasma gonadotrophins to respond to luteinizing hormone release hormone (LHRH) administration. Thus, it is suggested that bromocriptine may have an early direct effect on the ovary in hyperprolactinemic amenorrhea. SN - 0020-725X UR - https://www.unboundmedicine.com/medline/citation/40911/Bromocriptine_in_hyperprolactinemic_amenorrhea:_a_possible_early_effect_on_ovarian_steroidogenesis_ DB - PRIME DP - Unbound Medicine ER -